Steven K. Libutti, the new director of Rutgers Cancer Institute of New Jersey, will promote scientific discovery and expand cancer services through collaborations with Rutgers and RWJBarnabas Health.
Steven K. Libutti is the new director of Rutgers Cancer Institute of New Jersey and vice chancellor for cancer programs at Rutgers Biomedical and Health Sciences. His appointment is part of the effort to promote scientific discovery as well as expand comprehensive cancer services through collaborations with Rutgers and RWJBarnabas Health. Libutti will also serve as senior vice president of oncology services for RWJBarnabas Health, strengthening Rutgers’ partnership with the health care system.
A surgical oncologist whose specialty is addressing gastrointestinal malignancies including cancers of the liver and pancreas, Libutti is an internationally known expert in endocrine surgery and the treatment of neuroendocrine tumors. He had been the director for the Montefiore Einstein Center for Cancer Care and was a professor in and vice chair of the Department of Surgery and a professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System.
“Through his vast leadership and oncology expertise, Dr. Libutti will implement a unique vision to position Rutgers Cancer Institute of New Jersey as one of the top National Cancer Institute-designated Comprehensive Cancer Centers in the country as well as expand its impact throughout the RWJBarnabas Health system and the state,” says Brian Strom, the chancellor of Rutgers Biomedical and Health Sciences and executive vice president for health affairs.